Activation of DR3 signaling causes loss of ILC3s and exacerbates intestinal inflammation
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
TNF-like ligand 1 A (TL1A) and death receptor 3 (DR3) are a ligand-receptor pair involved in the pathogenesis of inflammatory bowel disease. Group 3 innate lymphoid cells (ILC3s) regulate intestinal immunity and highly express DR3. Here, we report that activation of DR3 signaling by an agonistic anti-DR3 antibody increases GM-CSF production from ILC3s through the p38 MAPK pathway. GM-CSF causes accumulation of eosinophils, neutrophils and CD11b+CD11c+ myeloid cells, resulting in loss of ILC3s from the intestine in an IL-23-dependent manner and exacerbating colitis. Blockade of GM-CSF or IL-23 reverses anti-DR3 antibody-driven ILC3 loss, whereas overexpression of IL-23 induces loss of ILC3s in the absence of GM-CSF. Neutralization of TL1A by soluble DR3 ameliorates both DSS and anti-CD40 antibody-induced colitis. Moreover, ILC3s are required for the deleterious effect of anti-DR3 antibodies on innate colitis. These findings clarify the process and consequences of DR3 signaling-induced intestinal inflammation through regulation of ILC3s.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
the NIDDK IBD Genetics Consortium, Barrett, J. C., the Belgian-French IBD Consortium, the Wellcome Trust Case Control Consortium, Hansoul, S., Nicolae, D. L., Cho, J. H., Duerr, R. H., Rioux, J. D., Brant, S. R., et al. (2008) · Nature Genetics · doi:10.1038/ng.175 · Cited by 2,593
Retinoic acid imprints gut-homing specificity on T cells
Iwata, M., Hirakiyama, A., Eshima, Y., Kagechika, H., Kato, C., & Song, S.-Y. (2004) · Immunity · doi:10.1016/j.immuni.2004.08.011 · Cited by 1,541
Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis
Bouskra, D., Brézillon, C., Bérard, M., Werts, C., Varona, R., Boneca, I. G., & Eberl, G. (2008) · Nature · doi:10.1038/nature07450 · Cited by 1,107
El-Behi, M., Ciric, B., Dai, H., Yan, Y., Cullimore, M., Safavi, F., Zhang, G.-X., Dittel, B. N., & Rostami, A. (2011) · Nature Immunology · doi:10.1038/ni.2031 · Cited by 1,071
Microbiota-dependent crosstalk between macrophages and ILC3 promotes intestinal homeostasis
Mortha, A., Chudnovskiy, A., Hashimoto, D., Bogunovic, M., Spencer, S. P., Belkaid, Y., & Merad, M. (2014) · Science · doi:10.1126/science.1249288 · Cited by 820
Myc Cooperates with Ras by Programming Inflammation and Immune Suppression
Kortlever, R. M., Sodir, N. M., Wilson, C. H., Burkhart, D. L., Pellegrinet, L., Brown Swigart, L., Littlewood, T. D., & Evan, G. I. (2017) · Cell · doi:10.1016/j.cell.2017.11.013 · Cited by 553
Guerra, E. S., Lee, C. K., Specht, C. A., Yadav, B., Huang, H., Akalin, A., Huh, J. R., Mueller, C., & Levitz, S. M. (2017) · PLOS Pathogens · doi:10.1371/journal.ppat.1006175 · Cited by 88
Research works printed but not linked: 59
- Meylan, F., Richard, A. C. & Siegel, R. M. TL1A and DR3, a TNF family ligand-receptor pair that promotes lymphocyte costimulation, mucosal hyperplasia, and autoimmune inflammation. Immunol. Rev. 244, 188–196 (2011). · DOI · Paper page
- Meylan, F. et al. The TNF-family receptor DR3 is essential for diverse T cell-mediated inflammatory diseases. Immunity 29, 79–89 (2008). · DOI · Paper page
- Meylan, F. et al. The TNF-family cytokine TL1A promotes allergic immunopathology through group 2 innate lymphoid cells. Mucosal Immunol. 7, 958–968 (2014). · DOI · Paper page
- Aiba, Y. & Nakamura, M. The role of TL1A and DR3 in autoimmune and inflammatory diseases. Mediat. Inflamm. 2013, 258164 (2013). · DOI
- Pappu, B. P. et al. TL1A-DR3 interaction regulates Th17 cell function and Th17-mediated autoimmune disease. J. Exp. Med. 205, 1049–1062 (2008). · DOI · Paper page
- Schreiber, T. H. et al. Therapeutic Treg expansion in mice by TNFRSF25 prevents allergic lung inflammation. J. Clin. Investig. 120, 3629–3640 (2010). · DOI · Paper page
- Khan, S. Q. et al. Cloning, expression, and functional characterization of TL1A-Ig. J. Immunol. 190, 1540–1550 (2013). · DOI
- Nishikii, H. et al. DR3 signaling modulates the function of Foxp3+ regulatory T cells and the severity of acute graft-versus-host disease. Blood 128, 2846–2858 (2016). · DOI
- Kim, B. S. et al. Treatment with agonistic DR3 antibody results in expansion of donor Tregs and reduced graft-versus-host disease. Blood 126, 546–557 (2015). · DOI
- Madireddi, S. et al. Regulatory T cell-mediated suppression of inflammation induced by DR3 signaling is dependent on galectin-9. J. Immunol. 199, 2721–2728 (2017). · DOI
- Jia, L. G. et al. A novel role for TL1A/DR3 in Protection against intestinal injury and infection. J. Immunol. 197, 377–386 (2016). · DOI
- Bamias, G., Jia, L. G. & Cominelli, F. The tumor necrosis factor-like cytokine 1A/death receptor 3 cytokine system in intestinal inflammation. Curr. Opin. Gastroenterol. 29, 597–602 (2013). · DOI
- Li, Z. et al. Death receptor 3 signaling controls the balance between regulatory and effector lymphocytes in SAMP1/YitFc mice with Crohn’s disease-like ileitis. Front. Immunol. 9, 362 (2018). · DOI
- Butto, L. F. et al. Death-domain-receptor 3 deletion normalizes inflammatory gene expression and prevents ileitis in experimental Crohn’s disease. Inflamm. Bowel Dis. 25, 14–26 (2019). · DOI
- Yamazaki, K. et al. Single nucleotide polymorphisms in TNFSF15 confer susceptibility to Crohn’s disease. Hum. Mol. Genet. 14, 3499–3506 (2005). · DOI · Paper page
- Siakavellas, S. I. & Bamias, G. Tumor necrosis factor-like cytokine TL1A and its receptors DR3 and DcR3: important new factors in mucosal homeostasis and inflammation. Inflamm. Bowel Dis. 21, 2441–2452 (2015).
- Yu, X. et al. TNF superfamily member TL1A elicits type 2 innate lymphoid cells at mucosal barriers. Mucosal Immunol. 7, 730–740 (2014). · DOI · Paper page
- Takedatsu, H. et al. TL1A (TNFSF15) regulates the development of chronic colitis by modulating both T-helper 1 and T-helper 17 activation. Gastroenterology 135, 552–567 (2008). · DOI · Paper page
- Lanier, L. L. Shades of grey–the blurring view of innate and adaptive immunity. Nat. Rev. Immunol. 13, 73–74 (2013). · DOI
- Kim BS, Artis D. Group 2 innate lymphoid cells in health and disease. Cold Spring Harb. Perspect. Biol. 7, a016337 (2015). · DOI · Paper page
- Geremia, A. & Arancibia-Carcamo, C. V. Innate lymphoid cells in intestinal inflammation. Front Immunol. 8, 1296 (2017). · DOI · Paper page
- Longman, R. S. et al. CX(3)CR1(+) mononuclear phagocytes support colitis-associated innate lymphoid cell production of IL-22. J. Exp. Med. 211, 1571–1583 (2014). · DOI · Paper page
- Griseri, T. et al. Granulocyte macrophage colony-stimulating factor-activated eosinophils promote interleukin-23 driven chronic colitis. Immunity 43, 187–199 (2015). · DOI · Paper page
- Pearson, C. et al. ILC3 GM-CSF production and mobilisation orchestrate acute intestinal inflammation. eLife 5, e10066 (2016). · DOI · Paper page
- Bernink, J. H. et al. Interleukin-12 and -23 control plasticity of CD127(+) group 1 and group 3 innate lymphoid cells in the intestinal lamina propria. Immunity 43, 146–160 (2015). · DOI · Paper page
- Takayama, T. et al. Imbalance of NKp44(+)NKp46(-) and NKp44(-)NKp46(+) natural killer cells in the intestinal mucosa of patients with Crohn’s disease. Gastroenterology 139, 882–892 (2010). 892 e881-883. · DOI · Paper page
- Spits, H. et al. Innate lymphoid cells–a proposal for uniform nomenclature. Nat. Rev. Immunol. 13, 145–149 (2013). · DOI · Paper page
- Qiu, J. et al. The aryl hydrocarbon receptor regulates gut immunity through modulation of innate lymphoid cells. Immunity 36, 92–104 (2012). · DOI · Paper page
- Sonnenberg, G. F., Monticelli, L. A., Elloso, M. M., Fouser, L. A. & Artis, D. CD4(+) lymphoid tissue-inducer cells promote innate immunity in the gut. Immunity 34, 122–134 (2011). · DOI · Paper page
- Eberl, G. et al. An essential function for the nuclear receptor RORgamma(t) in the generation of fetal lymphoid tissue inducer cells. Nat. Immunol. 5, 64–73 (2004). · DOI · Paper page
- Gerdes, J. et al. Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am. J. Pathol. 138, 867–873 (1991).
- Migone, T. S. et al. TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator. Immunity 16, 479–492 (2002). · DOI · Paper page
- Budihardjo, I., Oliver, H., Lutter, M., Luo, X. & Wang, X. Biochemical pathways of caspase activation during apoptosis. Annu. Rev. Cell Dev. Biol. 15, 269–290 (1999). · DOI · Paper page
- Vonarbourg, C. et al. Regulated expression of nuclear receptor RORgammat confers distinct functional fates to NK cell receptor-expressing RORgammat(+) innate lymphocytes. Immunity 33, 736–751 (2010). · DOI · Paper page
- Klose, C. S. N. et al. Differentiation of type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages. Cell 157, 340–356 (2014). · DOI · Paper page
- Srinivas, S. et al. Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus. BMC Dev. Biol. 1, 4 (2001). · DOI · Paper page
- Walker, J. A. & McKenzie, A. N. Development and function of group 2 innate lymphoid cells. Curr. Opin. Immunol. 25, 148–155 (2013). · DOI · Paper page
- Becher, B., Tugues, S. & Greter, M. GM-CSF: from growth factor to central mediator of tissue inflammation. Immunity 45, 963–973 (2016). · DOI · Paper page
- Satoh-Takayama, N. et al. The chemokine receptor CXCR6 controls the functional topography of interleukin-22 producing intestinal innate lymphoid cells. Immunity 41, 776–788 (2014). · DOI
- Macho-Fernandez, E. et al. Lymphotoxin beta receptor signaling limits mucosal damage through driving IL-23 production by epithelial cells. Mucosal Immunol. 8, 403–413 (2015). · DOI · Paper page
- Kim, M. Y. et al. Neonatal and adult CD4+ CD3- cells share similar gene expression profile, and neonatal cells up-regulate OX40 ligand in response to TL1A (TNFSF15). J. Immunol. 177, 3074–3081 (2006). · DOI
- Wang, Y. et al. Lymphotoxin beta receptor signaling in intestinal epithelial cells orchestrates innate immune responses against mucosal bacterial infection. Immunity 32, 403–413 (2010). · DOI · Paper page
- Eken, A., Singh, A. K., Treuting, P. M. & Oukka, M. IL-23R+ innate lymphoid cells induce colitis via interleukin-22-dependent mechanism. Mucosal Immunol. 7, 143–154 (2014). · DOI · Paper page
- Ridley, A. J. Rho GTPase signalling in cell migration. Curr. Opin. Cell Biol. 36, 103–112 (2015). · DOI · Paper page
- Kim, M. H., Taparowsky, E. J. & Kim, C. H. Retinoic acid differentially regulates the migration of innate lymphoid cell subsets to the gut. Immunity 43, 107–119 (2015). · DOI · Paper page
- Hepworth, M. R. et al. Innate lymphoid cells regulate CD4+ T-cell responses to intestinal commensal bacteria. Nature 498, 113–117 (2013). · DOI · Paper page
- Hepworth, M. R. et al. Immune tolerance. Group 3 innate lymphoid cells mediate intestinal selection of commensal bacteria-specific CD4(+) T cells. Science 348, 1031–1035 (2015). · DOI · Paper page
- Tiedje, C. et al. The RNA-binding protein TTP is a global post-transcriptional regulator of feedback control in inflammation. Nucleic Acids Res. 44, 7418–7440 (2016).
- Pobezinskaya, Y. L., Choksi, S., Morgan, M. J., Cao, X. & Liu, Z. G. The adaptor protein TRADD is essential for TNF-like ligand 1A/death receptor 3 signaling. J. Immunol. 186, 5212–5216 (2011). · DOI · Paper page
- Slebioda, T. J. et al. Triggering of TNFRSF25 promotes CD8(+) T-cell responses and anti-tumor immunity. Eur. J. Immunol. 41, 2606–2611 (2011). · DOI
- Castellanos, J. G. et al. Microbiota-induced TNF-like ligand 1A drives group 3 innate lymphoid cell-mediated barrier protection and intestinal T cell activation during colitis. Immunity 49, 1077–1089 e1075 (2018). · DOI · Paper page
- Chen, L. et al. IL-23 activates innate lymphoid cells to promote neonatal intestinal pathology. Mucosal Immunol. 8, 390–402 (2015). · DOI
- Paustian, A. M. S. et al. Continuous IL-23 stimulation drives ILC3 depletion in the upper GI tract and, in combination with TNFalpha, induces robust activation and a phenotypic switch of ILC3. PLoS ONE 12, e0182841 (2017). · DOI
- Kearney, C. J. & Martin, S. J. An inflammatory perspective on necroptosis. Mol. Cell 65, 965–973 (2017). · DOI · Paper page
- Tomura, M. et al. Monitoring cellular movement in vivo with photoconvertible fluorescence protein “Kaede” transgenic mice. Proc. Natl Acad. Sci. USA 105, 10871–10876 (2008). · DOI · Paper page
- Mackley, E. C. et al. CCR7-dependent trafficking of RORgamma(+) ILCs creates a unique microenvironment within mucosal draining lymph nodes. Nat. Commun. 6, 5862 (2015). · DOI · Paper page
- Uhlig, H. H. et al. Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology. Immunity 25, 309–318 (2006). · DOI · Paper page
- Lieschke, G. J., Rao, P. K., Gately, M. K. & Mulligan, R. C. Bioactive murine and human interleukin-12 fusion proteins which retain antitumor activity in vivo. Nat. Biotechnol. 15, 35–40 (1997). · DOI
- Pavlick, K. P. et al. Role of T-cell-associated lymphocyte function-associated antigen-1 in the pathogenesis of experimental colitis. Int Immunol. 18, 389–398 (2006). · doi:10.1093/intimm/dxh378
Cited by
Industrial carbon dioxide capture and utilization: state of the art and future challenges
Gao, W., Liang, S., Wang, R., Jiang, Q., Zhang, Y., Zheng, Q., Xie, B., Toe, C. Y., Zhu, X., Wang, J., et al. (2020) · Chemical Society Reviews · doi:10.1039/d0cs00025f · Cited by 1,388
Diversity and versatility of p38 kinase signalling in health and disease
Canovas, B., & Nebreda, A. R. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00322-w · Cited by 657
Innate Lymphoid Cells in Intestinal Homeostasis and Inflammatory Bowel Disease
Saez, A., Gomez-Bris, R., Herrero-Fernandez, B., Mingorance, C., Rius, C., & Gonzalez-Granado, J. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147618 · Cited by 197
Sun, H., Shu, J., Tang, J., Li, Y., Qiu, J., Ding, Z., Xuan, B., Chen, M., Gan, C., Lin, J., et al. (2024) · Immunology · doi:10.1111/imm.13784 · Cited by 54
“All the digital images were obtained with a NanoZoomer S60 (Hamamatsu Photonics, Hamamatsu City, Japan) and scored according to previous methods [47].”
MethodSelf-citation
Metadata
- Authors
- Li, J., Shi, W., Sun, H., Ji, Y., Chen, Y., Guo, X., Sheng, H., Shu, J., Zhou, L., Cai, T., & Qiu, J.
- Venue
- Nature Communications
- Published
- 2019-07-29
- Volume
- 10
- Issue
- 1
- Pages
- 3371-3371
- ISSN
- 2041-1723 (ISSN-L)
- OpenAlex
- W2965829044
- Cited by
- 63
- References
- 7
- FWCI
- 2.16
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Activation of DR3 signaling causes loss of ILC3s and exacerbates intestinal inflammation. https://app.cochat.ai/papers/10.1038/s41467-019-11304-8
- The paper
- Li, J., Shi, W., Sun, H., Ji, Y., Chen, Y., Guo, X., Sheng, H., Shu, J., Zhou, L., Cai, T., & Qiu, J. (2019). Activation of DR3 signaling causes loss of ILC3s and exacerbates intestinal inflammation. Nature Communications. https://doi.org/10.1038/s41467-019-11304-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.